Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

(Reuters) - Americans are still eagerly seeking prescriptions for Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO)'s weight-loss and diabetes drugs but ... to get off the FDA shortage list without ...

Analysis-Americans Hungry for Weight-Loss ... off the FDA shortage list without fully resolving the supply issue, seeking to stop compounders from making copycat versions of their drugs.

We’ll help fill some of the gaps, including which FDA-approved diabetes drugs can cause weight loss, how effective they are at reducing and managing body weight, and the possible side effects.